The comparison page
The homepage is a sortable, filterable list of every provider we track. The filter rail across the top controls what you see. The provider cards below update live.
Medication filter
Switch between tirzepatide, semaglutide, and retatrutide. Each approved medication has its own dose ladder and its own set of providers. Retatrutide is still in clinical trials, so its tab shows a Coming Soon panel until it clears the FDA.
Price filter
Toggles between Monthly, Bundle, and Starter pricing views. Monthly is recurring billing. Bundle is upfront multi-month. Starter shows the discounted intro offers some providers run for your first cycle.
Dose filter
Jump to the dose you are on. The card updates to show that tier's price.
Pricing language
- AVERAGE: the card's default headline price, an average across dose tiers.
- WHAT YOU ACTUALLY PAY: what you actually pay for the selected dose per billing cycle.
- WHAT YOU ACTUALLY GET: the total mg and weeks of supply in that cycle.
- YOUR VALUE: effective price per mg.
Key terms
Compounded vs Brand
Brand-name GLP-1s (Zepbound, Wegovy, etc.) come from the manufacturer. Compounded GLP-1s are made by a 503A or 503B pharmacy and are typically significantly cheaper.
503A vs 503B
503A pharmacies compound medications to order for an individual patient's prescription. 503B outsourcing facilities register with the FDA and make larger batches under stricter federal cGMP quality oversight.
Titration
A plan that starts at a low dose and gradually increases. Shown as a single plan row with multiple dose tiers.
BUD (Beyond-Use Date)
How long the compounded medication is stable after preparation. Varies by pharmacy.